CeriBell Inc CBLL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Ceribell Reports Third Quarter 2026 Financial Results
Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
Ceribell Reports Second Quarter 2026 Financial Results
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
Trading Information
- Previous Close Price
- $26.01
- Day Range
- $24.99–26.47
- 52-Week Range
- $11.12–28.87
- Bid/Ask
- $26.29 / $26.45
- Shares Outstanding
- 38.84M
- Market Cap
- $1.02B
- Volume/Avg
- 75,341 / 467,613
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 9.05
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 300
- Website
- https://www.ceribell.com
Valuation
Metric | CBLL |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 8.59 |
Price/Sales | 9.05 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | CBLL |
|---|---|
Quick Ratio | 7.50 |
Current Ratio | 8.18 |
Interest Coverage | −45.15 |
Quick Ratio
CBLL
Profitability
Metric | CBLL |
|---|---|
Return on Assets (Normalized) | −29.89% |
Return on Equity (Normalized) | −37.94% |
Return on Invested Capital (Normalized) | −31.87% |
Return on Assets
CBLL
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|Tm!&#?n | LOCK|>Tj<& | $197B | |||
| Medtronic PLC MDT | LOCK|txT@J!$ | LOCK|f@v@& | $134B | |||
| Stryker Corp SYK | LOCK|Nf!@Z?% | LOCK|tcg | $128B | |||
| Boston Scientific Corp BSX | LOCK|@>dGbzC | LOCK|QfGk^ | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|!!!%@^j | LOCK|fjJ@ | $58B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|$?>t<& | LOCK|jWk | $38B | |||
| DexCom Inc DXCM | LOCK|??Jr$j&h | LOCK|$wR<d | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|%@ | LOCK|?t | $30B | |||
| Steris PLC STE | LOCK|%s&<C$! | LOCK|kvSv | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|@>?pQT<# | LOCK|?% | $20B |
United States